RERE-SLC2A7 Fusion FISH Probe
The RERE-SLC2A7 Fusion FISH Probe is used to confirm a fusion of the RERE and SLC2A7 genes. The fusion of the RERE and SLC2A7 genes has been associated with Uterine Corpus Endometrial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| RERE-SLC2A7-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| RERE-SLC2A7-20-RERE | 20 (40 μL) | 200 μL |
|
|
| RERE-SLC2A7-20-REOR | 20 (40 μL) | 200 μL |
|
|
| RERE-SLC2A7-20-REGO | 20 (40 μL) | 200 μL |
|
|
| RERE-SLC2A7-20-REGR | 20 (40 μL) | 200 μL |
|
|
| RERE-SLC2A7-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| RERE-SLC2A7-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| RERE-SLC2A7-20-OROR | 20 (40 μL) | 200 μL |
|
|
| RERE-SLC2A7-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| RERE-SLC2A7-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| RERE-SLC2A7-20-GORE | 20 (40 μL) | 200 μL |
|
|
| RERE-SLC2A7-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| RERE-SLC2A7-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| RERE-SLC2A7-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| RERE-SLC2A7-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| RERE-SLC2A7-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| RERE-SLC2A7-20-GROR | 20 (40 μL) | 200 μL |
|
|
| RERE-SLC2A7-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| RERE-SLC2A7-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| RERE-SLC2A7-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| RERE-SLC2A7-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| RERE-SLC2A7-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| RERE-SLC2A7-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| RERE-SLC2A7-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| RERE-SLC2A7-20-AQAQ | 20 (40 μL) | 200 μL |
|
RERE Gene Summary
This gene encodes a member of the atrophin family of arginine-glutamic acid (RE) dipeptide repeat-containing proteins. The encoded protein co-localizes with a transcription factor in the nucleus, and its overexpression triggers apoptosis. A similar protein in mouse associates with histone deacetylase and is thought to function as a transcriptional co-repressor during embryonic development. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Gene Name: Arginine-glutamic Acid Dipeptide Repeats
Chromosome: CHR1: 8412463 -8877699
Locus: 1p36.23
SLC2A7 Gene Summary
SLC2A7 belongs to a family of transporters that catalyze the uptake of sugars through facilitated diffusion (Li et al., 2004). This family of transporters shows conservation of 12 transmembrane helices as well as functionally significant amino acid residues (Joost and Thorens, 2001 [PubMed 11780753]).[supplied by OMIM, Mar 2008]
Gene Name: Solute Carrier Family 2 Member 7
Chromosome: CHR1: 9063358 -9086404
Locus: 1p36.23
Gene Diseases
The RERE SLC2A7 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Uterine Corpus Endometrial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|